IOL Chemicals and Pharmaceuticals Limited — Important, 05-03-2025: General Updates

The European Directorate for the Quality of Medicines & Health Care (EDQM) has issued a Certificate of Suitability for IOL Chemicals and Pharmaceuticals' active pharmaceutical ingredient (API), Quetiapine Fumarate. This certification allows the company to export Quetiapine Fumarate to European nations and other markets recognizing CEPs. Quetiapine Fumarate is an antipsychotic medication used for treating various mental health disorders. The certification represents a significant opportunity for the company to expand its export potential and enhance market positioning. Investors should monitor this development as it could positively influence future revenue streams.